[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @OncoThor Thor Halfdanarson Thor Halfdanarson posts on X about all the, hills, lebanon, mayo the most. They currently have XXXXX followers and X posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::814218641579376641/interactions)  - X Week XXXXX +1,116% - X Months XXXXXX +35% - X Year XXXXXXX +197% ### Mentions: X [#](/creator/twitter::814218641579376641/posts_active)  - X Week X -XX% - X Months XX -XX% - X Year XX +332% ### Followers: XXXXX [#](/creator/twitter::814218641579376641/followers)  - X Week XXXXX +0.60% - X Months XXXXX +9.60% - X Year XXXXX +17% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::814218641579376641/influencer_rank)  ### Social Influence [#](/creator/twitter::814218641579376641/influence) --- **Social category influence** [countries](/list/countries) XX% [stocks](/list/stocks) XX% **Social topic influence** [all the](/topic/all-the) 20%, [hills](/topic/hills) 20%, [lebanon](/topic/lebanon) 20%, [mayo](/topic/mayo) 20%, [panc](/topic/panc) 20%, [radar](/topic/radar) 20%, [ozzy](/topic/ozzy) 20%, [ozzyosbourne](/topic/ozzyosbourne) 20%, [threshold](/topic/threshold) XX% **Top accounts mentioned or mentioned by** [@rohitthum](/creator/undefined) [@dianereidylagun](/creator/undefined) [@lisabodei](/creator/undefined) [@natasharekhtman](/creator/undefined) [@anistoumeh](/creator/undefined) [@clayreedmd](/creator/undefined) [@ozzyosbourne](/creator/undefined) [@jacapdevila](/creator/undefined) [@rohit_thum](/creator/undefined) ### Top Social Posts [#](/creator/twitter::814218641579376641/posts) --- Top posts by engagements in the last XX hours "Another Mayo Clinic post-ASCO oncology conference wrapped up and as is now customary for me I celebrated a successful conference hitting the trails. Lebanon Hills in the Twin Cities has some great trails. Thanks to all the speakers attendees and supporters"  [@OncoThor](/creator/x/OncoThor) on [X](/post/tweet/1946725588892369138) 2025-07-20 00:15:23 UTC 5038 followers, XXX engagements "On my NET PubMed radar this morning from @rohit_thum et al. at MSKCC. DLL3 positive in XX% of GEPNECs and XX% of well diff G3 panc NETs and DLL3+ was associated with worse outcomes in that group. Check it out @lisabodei @DianeReidyLagun @natasharekhtman"  [@OncoThor](/creator/x/OncoThor) on [X](/post/tweet/1946188479005589987) 2025-07-18 12:41:06 UTC 5039 followers, 3423 engagements "@ClayReedMD @OzzyOsbourne I so wish I had seen him live. You may enjoy the obit in NY Times. Brilliantly written and Ozzy would have loved it"  [@OncoThor](/creator/x/OncoThor) on [X](/post/tweet/1948077929620976009) 2025-07-23 17:49:06 UTC 5039 followers, XX engagements "@rohit_thum @AnisToumeh @lisabodei @DianeReidyLagun @natasharekhtman I agree and second the comment on Amgen. We have treated a few pts with NECs but not yet a G3 NET patient but we are routinely staining for DLL3 now. Also agree with the comment on the DLL3 threshold. With obrixtamig XX% threshold may be reasonable right @Ja_Capdevila"  [@OncoThor](/creator/x/OncoThor) on [X](/post/tweet/1946214136783794270) 2025-07-18 14:23:03 UTC 5039 followers, XXX engagements "@DianeReidyLagun @rohit_thum Agree there is a large unmet need for later lines of G3 pNETs and for refractory lung NETs. Trials needed for DLL3-targeting agents in these cohorts are definitely needed. Strong work Lots of goodies in the manuscript so NET folks check it out"  [@OncoThor](/creator/x/OncoThor) on [X](/post/tweet/1946190428006400117) 2025-07-18 12:48:51 UTC 5039 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@OncoThor Thor Halfdanarson
Thor Halfdanarson posts on X about all the, hills, lebanon, mayo the most. They currently have XXXXX followers and X posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXX +1,116%
- X Months XXXXXX +35%
- X Year XXXXXXX +197%
Mentions: X #
- X Week X -XX%
- X Months XX -XX%
- X Year XX +332%
Followers: XXXXX #
- X Week XXXXX +0.60%
- X Months XXXXX +9.60%
- X Year XXXXX +17%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence countries XX% stocks XX%
Social topic influence all the 20%, hills 20%, lebanon 20%, mayo 20%, panc 20%, radar 20%, ozzy 20%, ozzyosbourne 20%, threshold XX%
Top accounts mentioned or mentioned by @rohitthum @dianereidylagun @lisabodei @natasharekhtman @anistoumeh @clayreedmd @ozzyosbourne @jacapdevila @rohit_thum
Top Social Posts #
Top posts by engagements in the last XX hours
"Another Mayo Clinic post-ASCO oncology conference wrapped up and as is now customary for me I celebrated a successful conference hitting the trails. Lebanon Hills in the Twin Cities has some great trails. Thanks to all the speakers attendees and supporters"
@OncoThor on X 2025-07-20 00:15:23 UTC 5038 followers, XXX engagements
"On my NET PubMed radar this morning from @rohit_thum et al. at MSKCC. DLL3 positive in XX% of GEPNECs and XX% of well diff G3 panc NETs and DLL3+ was associated with worse outcomes in that group. Check it out @lisabodei @DianeReidyLagun @natasharekhtman" @OncoThor on X 2025-07-18 12:41:06 UTC 5039 followers, 3423 engagements
"@ClayReedMD @OzzyOsbourne I so wish I had seen him live. You may enjoy the obit in NY Times. Brilliantly written and Ozzy would have loved it" @OncoThor on X 2025-07-23 17:49:06 UTC 5039 followers, XX engagements
"@rohit_thum @AnisToumeh @lisabodei @DianeReidyLagun @natasharekhtman I agree and second the comment on Amgen. We have treated a few pts with NECs but not yet a G3 NET patient but we are routinely staining for DLL3 now. Also agree with the comment on the DLL3 threshold. With obrixtamig XX% threshold may be reasonable right @Ja_Capdevila" @OncoThor on X 2025-07-18 14:23:03 UTC 5039 followers, XXX engagements
"@DianeReidyLagun @rohit_thum Agree there is a large unmet need for later lines of G3 pNETs and for refractory lung NETs. Trials needed for DLL3-targeting agents in these cohorts are definitely needed. Strong work Lots of goodies in the manuscript so NET folks check it out" @OncoThor on X 2025-07-18 12:48:51 UTC 5039 followers, XXX engagements